HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) All Versions of this Article: adc.2007.123232v1 92/12/1062    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in ADC Online Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cameron, J C Articles by Booy, R Search for Related Content PubMed PubMed Citation Articles by Cameron, J C Articles by Booy, R Topic Collections Editor's choice Relevant Article

Severe complications of chickenpox in hospitalised children in the UK and Ireland

¹ Health Protection Scotland, Glasgow, UK
² Department of Clinical Science at South Bristol, Unit of Child Health, University of Bristol, Bristol, UK
³ Division of Child Health and Vaccine Institute, St George’s, University of London, London, UK
⁴ National Centre for Immunisation Research and Surveillance, University of Sydney, NSW, Australia

Correspondence to:
Dr J Claire Cameron, Health Protection Scotland, Glasgow G3 7LN, Scotland, UK; claire.cameron{at}hps.scot.nhs.uk

Aims: To estimate the annual incidence of hospitalisations due to severe complications of varicella, describe the complications and estimate annual mortality.

Methods: Active surveillance throughout the UK and Ireland for 13 months by paediatricians notifying cases to the British Paediatric Surveillance Unit and completing a questionnaire. The case definition was any child aged <16 years hospitalised with complicated varicella, as defined by a list of conditions, or admitted to ICU/HDU with varicella.

Results: 188 cases were notified for the surveillance period, of which 112 (0.82/100 000 children/year) met the case definition and were not duplicates. Confirmed cases had a median age of 3 years (range 0–14). The complications were: bacteraemia/septic shock (n = 30), pneumonia (n = 30), encephalitis (n = 26), ataxia (n = 25), toxic shock syndrome/toxin-mediated disease (n = 14), necrotising fasciitis (n = 7), purpura fulminans/disseminated coagulopathy (n = 5), fulminant varicella (n = 5) and neonatal varicella (n = 3). 52 children (46%) had additional bacterial infections. Six deaths were due, or possibly due, to varicella, including one intrauterine death. Four of the other five children who died (ages 2–14 years) had a pre-existing medical condition. Sequelae on discharge were reported for 41 cases (40%), most frequently ataxia or skin scarring. The median length of hospital stay was 7 days (range 1–68).

Conclusions: This study provides a minimum estimate of severe complications and death resulting from varicella in children in the UK and Ireland. Most complications, excluding deaths, occur in otherwise healthy children and thus would be preventable only through a universal childhood immunisation programme.

This article has been cited by other articles:

				A Knorr, E Hutchison, and A Finn Varicella vaccination for HIV-infected children Arch. Dis. Child., September 1, 2008; 93(9): 812 - 812. [Full Text] [PDF]

				F M de Benedictis and P Osimani Necrotising fasciitis complicating varicella Arch. Dis. Child., July 1, 2008; 93(7): 619 - 619. [Full Text] [PDF]

				Should the UK introduce varicella vaccine? Arch. Dis. Child., December 1, 2007; 92(12): 1051 - 1052.